利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

66 条记录 (耗时 0.059 秒)

    Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
    51.
    发明授权
    Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom 失效
    被含有一个氮原子的五，六或七元杂环取代的咪唑烷基

    公开(公告)号：US6100279A

    公开(公告)日：2000-08-08

    申请号：US185973

    申请日：1998-11-05

    申请人： Wayne D. Vaccaro ,  Ronald L. Wolin ,  Daniel M. Solomon ,  Robert G. Aslanian ,  John J. Piwinski ,  Stuart B. Rosenblum

    发明人： Wayne D. Vaccaro ,  Ronald L. Wolin ,  Daniel M. Solomon ,  Robert G. Aslanian ,  John J. Piwinski ,  Stuart B. Rosenblum

    IPC分类号： A61K31/415 ,  A61K31/445 ,  A61K31/495 ,  A61K45/06 ,  C07D401/06 ,  C07D403/06

    CPC分类号： C07D401/06 ,  A61K31/415 ,  A61K31/445 ,  A61K31/495 ,  A61K45/06 ,  C07D403/06

    摘要： Disclosed are compounds of Formula I ##STR1## or pharmaceutically acceptable salts or solvates thereof. Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier and an effective amount of a Compound of Formula I. Further disclosed is a method of treating allergy (for example asthma), inflammation, hypotension, raised intraocular pressure (such as glaucoma)--i.e., a method of lowering intraocular pressure, sleeping disorders, states of hyper and hypo motility and acidic secretion of the gastrointestinal tract, hypo and hyperactivity of the central nervous system (for example, agitation and depression) and other CNS disorders (such as Alzheimer's, schizophrenia, obesity and migraine) comprising administering an effective amount of a compound of Formula I to a patient in need of such treatment. Also disclosed are methods for treatment of upper airway allergic responses comprising administering a compound, or salt or solvate thereof, of formula I in combination or admixture with a histamine H, receptor antagonist.

    摘要翻译： 公开了式I的化合物或其药学上可接受的盐或溶剂化物。 还公开了包含药学上可接受的载体和有效量的式I化合物的药物组合物。还公开了治疗过敏（例如哮喘），炎症，低血压，升高的眼内压（如青光眼）的方法， 降低眼内压，睡眠障碍，超低运动状态和胃肠道酸性分泌的方法，中枢神经系统的低血压和多动症（例如，激动和抑郁）和其他CNS疾病（例如阿兹海默氏症，精神分裂症 ，肥胖症和偏头痛）包括向需要这种治疗的患者施用有效量的式I化合物。 还公开了治疗上呼吸道过敏反应的方法，包括与组胺H受体拮抗剂组合或混合施用式I化合物或其盐或溶剂合物。

    Unbridged bis-aryl carbinol derivatives compositions and methods of use
    59.
    发明授权
    Unbridged bis-aryl carbinol derivatives compositions and methods of use 失效
    未桥连的双芳基甲醇衍生物组合物和使用方法

    公开(公告)号：US5665735A

    公开(公告)日：1997-09-09

    申请号：US459149

    申请日：1995-06-02

    申请人： Richard Friary ,  John J. Piwinski ,  Jesse K. Wong

    发明人： Richard Friary ,  John J. Piwinski ,  Jesse K. Wong

    IPC分类号： A61K31/4427 ,  A61K31/4433 ,  A61K31/445 ,  A61P11/00 ,  A61P37/08 ,  C07D401/06 ,  C07D401/14 ,  C07D409/14 ,  C07D417/14 ,  C07D211/22 ,  C07D211/26 ,  C07D211/32

    CPC分类号： C07D401/14 ,  C07D401/06 ,  C07D409/14 ,  C07D417/14

    摘要： Disclosed is a compound of Formula 1.0: ##STR1## or a pharmaceutically acceptable salt or solvate thereof, wherein: AR.sup.1 represents ##STR2## AR.sup.2 represents ##STR3## or a five-membered heterocyclic aromatic group selected from the group consisting of Formulas I to XII, wherein the substitutable carbon atoms of the five-membered heterocyclic group can optionally be substituted with a group R.sup.1.Also disclosed are pharmaceutical compositions containing compounds of Formula 1.0.Further disclosed is a method for treating asthma, allergy and inflammation by administering an anti-asthmatic, anti-allergic or anti-inflammatory, respectively, effective amount of a compound of Formula 1.0.

    摘要翻译： 公开了式1.0的化合物：其中：AR1表示SEQ ID NO：表示选自下式的五元杂环芳族基团：式（1.0）或其药学上可接受的盐或溶剂合物， I至XII，其中五元杂环基的可取代的碳原子可任选地被基团R 1取代。 还公开了含有式1.0化合物的药物组合物。 还公开了一种通过分别施用抗哮喘，抗过敏或抗炎的有效量的式1.0化合物来治疗哮喘，过敏和炎症的方法。